News Search Results
Sep 30, 2025, 10:50 ET Dialysis Equipment Market to Reach US$ 19.14 billion by 2031 at CAGR of 5.9% | Business Market Insights
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media, and telecommunications, as well as chemicals and materials.
More news about: Business Market Insights
Sep 30, 2025, 10:40 ET RTLS Market For Healthcare Is Projected To Reach US$10.66 Billion By 2031, at CAGR Of 18.6% Amid Growing Chronic Diseases Burden | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media, and telecommunications, as well as chemicals and materials.
More news about: The Insight Partners
Sep 30, 2025, 10:30 ET Pressure Monitoring Devices Market Outlook: Increasing Remote Patient Monitoring to Drive Market Growth to US$26.6 Billion by 2033 | Business Market Insights
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media, and telecommunications, as well as chemicals and materials.
More news about: Business Market Insights
Sep 30, 2025, 10:20 ET Active Pharmaceutical Ingredients (API) Market to Reach USD 445.7 Billion by 2035 | Growing at a CAGR 7.15% Driving Innovation, Cost Efficiency, and Global Drug Supply Resilience
communicable disease APIs are also experiencing notable growth. By End User: Pharmaceutical and biotechnology companies dominate consumption, leveraging APIs for drug development and commercial production, while contract research organizations (CROs) and
More news about: Vantage Market Research
Sep 30, 2025, 10:15 ET Joint Reconstruction Devices Market Reach US$ 30,573.75 Million by 2033 at CAGR of 5.0% | Business Market Insights
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media, and telecommunications, as well as chemicals and materials.
More news about: Business Market Insights
Sep 30, 2025, 10:01 ET Peritoneal Dialysis Equipment Market to Reach US$4.09 Billion by 2031 at 6.6% CAGR | Business Market Insights
to Help Support Better Infection Management in Peritoneal Dialysis Patients- In February 2025, Kidney Research UK invested in the UK-based biotechnology company, MicroBioSensor, to support the development of a device designed to detect peritonitis in peritoneal dialysis fluid rapidly. This innovation
More news about: Business Market Insights
Sep 30, 2025, 10:01 ET Insurance Third-Party Administrator Market is Expected to Reach US$681.16 Million By 2031 at a CAGR of 7.6% | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media, and telecommunications, as well as chemicals and materials.
More news about: The Insight Partners
Sep 30, 2025, 09:03 ET Arzeda to Lead Major NSF-Funded Initiative Advancing Electricity-Driven Cell-Free Biomanufacturing Through AI-Designed Enzymes
https://www.nsf.gov/tip/updates/nsf-invests-more-32m-biotechnology-accelerating-adoption. About Arzeda Arzeda
More news about: Arzeda
Sep 30, 2025, 09:00 ET K18 and Future Society Launch First-Ever Biotech Beauty Collaboration With Limited-Edition Floating Forest Hair Mask
Hair Mask is powered by K18's patented K18PEPTIDE™ and infused with Future Society's Floating Forest fragrance, proving that biotechnology can deliver both functional performance and deeply emotive sensory experiences. The limited-edition launch brings together K18's category-defining
More news about: K18 Biomimetic Hairscience
Sep 30, 2025, 08:48 ET C3 International and King Faisal Specialist Hospital & Research Centre Conclude Landmark Global Summit Series with General David Petraeus in New York City and Dr. Majid Alfayyadh in Tokyo
contributions to cancer innovation. Gifts, Inc. (Tokyo) – celebrated for pioneering advancements in regenerative medicine and biotechnology. "From New York to Tokyo, these C3 Davos of Healthcare™Summits demonstrated the innovation and potential
More news about: C3 International Davos of Healthcare™ Summit
Sep 30, 2025, 08:33 ET Lakewood-Amedex Biotherapeutics to Present at BioFlorida Regional Event at The Roskamp Institute
Lakewood-Amedex Biotherapeutics Inc., a clinical-stage biotechnology company advancing a novel class of potent, fast-acting, broad-spectrum antimicrobials for infectious diseases called the Bisphosphocin®
More news about: Lakewood-Amedex Inc.
Sep 30, 2025, 08:30 ET From Research to GMP-Ready Cell Lines: Bridging the Development Gap, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Sep 30, 2025, 08:30 ET Moving the Needle in Vaccine Trials: Optimizing Digital Endpoint and Operational Strategies to Enable Study Success, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Sep 30, 2025, 08:30 ET Beyond 3+3: Rethinking Early-Phase Oncology Study Design, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Sep 30, 2025, 08:30 ET Amorphical Announces Positive Interim Results from Ongoing Clinical Trial in Crohn's Disease
Amorphical is a biotechnology company advancing a new class of nano-amorphous mineral pharmacologic agents. Leveraging a proprietary, nature-inspired platform, Amorphical aims
More news about: Amorphical
Sep 30, 2025, 08:20 ET Spectrum Science Acquires Return on Focus, Expanding Strategic Capabilities to Drive Brand Success through Proprietary, Evidence-Based Approach to Positioning
Focus operates in complex, high-impact therapeutic areas including oncology, immunology and rare disease across a diverse range of pharmaceutical, biotechnology and specialty care companies. Over the past five years, Return on Focus has worked with more than 40 companies, including seven of the top 10 pharmaceutical
More news about: Spectrum Science
Sep 30, 2025, 07:30 ET Origin Agritech Announces Investment Agreements, Including Investment from Origin CEO Weibin Yan
infusions of $2,400,000 from our CEO and $1,481,250 from institutional investors will support Origin's continued expansion in China's agricultural biotechnology sector, including enhanced research and development capabilities, expanded market penetration, and strengthened distribution networks.
More news about: Origin Agritech Limited
Sep 30, 2025, 07:30 ET Soligenix Announces Expansion of European Medical Advisory Board for Cutaneous T-Cell Lymphoma
procurement contracts with the U.S. Government or other countries, that it will be able to compete with larger and better financed competitors in the biotechnology industry, that changes in health care practice, third party reimbursement limitations and Federal and/or state health care reform initiatives will
More news about: SOLIGENIX, INC.
Sep 30, 2025, 07:00 ET NLS Pharmaceutics Shareholders Approve Merger with Kadimastem and Related Proposals at Extraordinary General Meeting
Vote clears final corporate milestone, paving the way for the closing of the merger and the combined company of NewCelX Ltd., a Nasdaq-listed biotechnology company ZURICH, Sept.
More news about: NLS Pharmaceutics Ltd.; Kadimastem Ltd.
Sep 29, 2025, 17:59 ET WallachBeth Capital Announces Pricing of bioAffinity Technologies Public Offering for $4.8m
bioAffinity Technologies, Inc. (NASDAQ: BIAF and BIAFW) a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer has priced a public offering of securities as described
More news about: WallachBeth Capital LLC
Sep 29, 2025, 16:05 ET Soligenix Announces Closing of $7.5 Million Public Offering
procurement contracts with the U.S. Government or other countries, that it will be able to compete with larger and better financed competitors in the biotechnology industry, that changes in health care practice, third party reimbursement limitations and Federal and/or state health care reform initiatives will
More news about: SOLIGENIX, INC.
Sep 29, 2025, 14:15 ET Cell X Technologies and BioLamina enter a collaboration to advance standardization in iPSC-based therapeutics
www.cellxtechnologies.com About BioLamina BioLamina is a biotechnology company with a scientific base and heritage in matrix biology and cell culture research. It supports scientists who have struggled for decades to
More news about: Cell X Technologies, Inc
Sep 29, 2025, 14:04 ET Surgical Staplers Market To Grow US$ 10,587.21 Million By 2033, Registering A Robust CAGR Of 5.9% | Business Market Insights
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media, and telecommunications, as well as chemicals and materials.
More news about: Business Market Insights
Sep 29, 2025, 13:48 ET Vantage Market Research: Global Companion Diagnostics Market Size & Share to Surpass USD 31.75 Billion by 2035, Growing at a CAGR 11.75% | Powering Precision Medicine, Targeted Therapies and Next-Gen Drug Development
market research reports and actionable intelligence across healthcare, biotechnology, and advanced cell therapies. Our globally recognized insights empower stakeholders to make informed decisions, anticipate trends, and capitalize
More news about: Vantage Market Research
Sep 29, 2025, 11:58 ET Interventional Cardiology Devices Market to Reach US$39,234.52 million by 2033, at CAGR of 9.0% | Business Market Insights
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media, and telecommunications, as well as chemicals and materials.
More news about: Business Market Insights